Skip to main content

Table 2 Clinical Details of Patients

From: A microarray study of gene and protein regulation in human and rat brain following middle cerebral artery occlusion

Patient no. Age/sex Survival after stroke NIHSS on admission Hypertensiona Coronary artery disease Atrial fibrillation History of TIA/previous stroke Hypercholesterolemiab Smoking Obesityc Cause of death Antiplatelets Statinsd RSA-be
1 63/F 2 days 26 Yes No No No No No No Large ischemic stroke No No Yes
2 84/M 3 days 21 Yes Yes No No No Yes No Malignant stroke No No No
3 68/M 3 days 24 Yes Yes No No Yes No No Brain oedema No No Yes
4 84/M 6 days 22 Yes Yes No No No No No Cardiac failure Yes Yes No
5 51/M 9 days 25 Yes No No Yes No No No Respiratory infection Yes No No
6 74/M 15 days 22 Yes Yes No No No No Yes Heart attack Yes No Yes
7 86/M 15 days 14 Yes Yes No No Yes No No Urinary infection Yes No No
8 58/M 17 days 16 Yes Yes No No Yes Yes No Cardiac infarction Yes No No
9 74/M 20 days 12 Yes Yes No No No No No Bronchial aspiration Yes No No
10 73/M 26 days 14 Yes Yes No No Yes No Yes Respiratory infection Yes No Yes
11 75/M 29 days 20 No Yes Yes No No Yes No Septic shock Yes No Yes
12 60/F 37 days 18 Yes Yes No No Yes Yes No Pulmonary embolism Yes No No
  1. a Blood pressure greater than 135/85 mmHg.
  2. b Serum total cholesterol levels greater than 5.2 mmol.
  3. c Body mass index greater than 30.
  4. d Patients who were on statins before the ischemic stroke.
  5. e Patients taking either angiotensin converting enzyme inhibitors or angiotensin type I receptor antagonists.
  6. M = male; F = female; NIHSS = NIH Stroke Scale; TIA = Transient Ischaemic Attack.